5 Year History

FIVE YEAR STATEMENT

 

2018

£'m

2017

£’m

2016

£’m

2015

£’m

2014

£’m

Turnover^

1,464.5

1,245.1

1,016.3

1,003.3

994.9

Profit before tax^

88.0

77.5

62.1

52.8

54.8

Adjusted profit before tax*^

92.4

75.5

64.4

57.8

52.2

Earnings per share^

137.8p

124.2p

98.9p

84.1p

88.7p

Adjusted earnings per share*^

145.0p

120.9p

102.8p

92.1p

84.1p

Dividends per share

53.7p

44.1p

37.5p

34.0p

32.0p

Capital expenditure

59.2

48.6

34.1

23.3

22.9

Net (debt)/funds

20.6

(11.0)

17.8

(17.3)

(17.0)

Net assets

479.9

421.4

368.0

332.4

302.7

 

*    Adjusted profit before tax and earnings per share exclude the effects of net IAS 41 valuation movement and acquisition related amortisation in 2018 and 2017; the effects of net IAS 41 valuation movement, acquisition related amortisation and impairment of goodwill in 2016; net IAS 41 valuation movement and acquisition related amortisation in 2015 and release of contingent consideration and net IAS 41 valuation movement on biological assets in 2014. These are the measures used by the Board to assess the Group’s underlying performance.

^    2017 and 2016 reflect continuing operations only.

Dividends per share relate to dividends declared in respect of that year.